Inventor · disambiguated record
Guangli Yang
Also filed as: YANG GUANGLI
7 granted patents·3 pending applications·56 citations·filing 2003–2023
78Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER4TSUJI MORIYA2DANISHEFSKY SAMUEL J1SLOAN-KETTERING INST FOR CANCER RES1UNIV CITY1
Top patents by PatentIndex Score
10 records- 0191US7273852B2Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseasesUNIV CITY·Filed 2003·Granted Sep 25, 2007·54 cites·9 claims
- 0269US8883745B2C—glycolipids with enhanced Th-1 profileTSUJI MORIYA·Filed 2007·Granted Nov 11, 2014·1 cites·22 claims
- 0363US9303009B2Migrastatins and uses thereofDANISHEFSKY SAMUEL J·Filed 2012·Granted Apr 5, 2016·1 cites·25 claims
- 0462US2025230124A1Small molecule inhibitors of id proteinsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 0553US8252909B2Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseasesTSUJI MORIYA·Filed 2005·Granted Aug 28, 2012·0 cites·2 claims
- 0653US2022356163A1SMALL MOLECULE INHIBITORS OF Id PROTEINSMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 0751US10975051B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 13, 2021·0 cites·25 claims
- 0849US2022257601A1Inhibitors of prc1 for treatment of cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 0947US11098021B2Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 24, 2021·0 cites·25 claims
- 1044US9546146B2Migrastatins and uses thereofSLOAN-KETTERING INST FOR CANCER RES·Filed 2016·Granted Jan 17, 2017·0 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Guangli Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →